BMT CTN Protocol 1704 CHARM

Composite Health Assessment Model for Older Adults: Applying Pre-transplant Comorbidity, Geriatric Assessment, and Biomarkers to Predict Non-Relapse Mortality after Allogeneic Transplantation

Below are protocol-related documents, which may be periodically updated.

             Protocol Co-Chair: Andrew Artz, MD

             Protocol Co-Chair: Mohamed Sorror, MD, MSc

             Protocol Officer: Wael Saber, MD, MS

             Protocol Coordinator: Kelsey Schertz        

The BMT CTN is committed to including widespread transplant community participation in these trials. For information on how to apply to participate on this study, please contact the Protocol Coordinator Kelsey Schertz at for details.